The first two trial medications are high-dose metformin - a diabetes drug that may help regenerate myelin - and a version of high-dose alpha-lipoic acid, which is a food supplement that acts as an anti-oxidant. It has already been approved in Germany for treating neuropathy - weakness, pain, numbness or tingling in damaged nerves.
Not content with rats, I thought they were going to start on octupi next…
This topic was automatically closed 14 days after the last reply. New replies are no longer allowed.